News on Medial

MedySeva raises Rs 4 Cr led by Unicorn India Ventures

EntrackrEntrackr · 3m ago
MedySeva raises Rs 4 Cr led by Unicorn India Ventures
Medial

Healthtech startup MedySeva has raised Rs 4 crore in a seed round led by Unicorn India Ventures. The proceeds will be used to expand phygital healthcare clinics across tier-II and tier-III locations, upgrade its telemedicine platform, strengthen digital infrastructure, increase patient outreach, and build on-ground operations and clinical support teams. Founded in 2022 by Dr. Vishesh Kasliwal, MedySeva provides teleconsultation and in-person doctor services through a hybrid healthcare model for rural and semi-urban regions. The company connects patients to doctors across medical specialities using a central telemedicine platform supported by physical clinics. MedySeva claims to have delivered 1,00,000 consultations in the last 12 months with a 60% repeat-patient rate. The firm aims to scale to 2 lakh annual consultations in 18 months. It has partnered with medical colleges to set up satellite clinics and onboarded doctors from 10 medical specialties. The brand has also tied up with pharmacies and healthcare providers to build a local care network. MedySeva plans to open over 500 phygital healthcare centres across India over the next 18–24 months and enter five new states through institutional and state-level partnerships. MedySeva competes with primary healthcare and telemedicine players such as Practo, Medibuddy, Clinikk, HealthPlix, CureBay, and eSanjeevani in rural and semi-urban healthcare access.

Related News

StampMyVisa raises Rs 4 Cr in bridge round led by Unicorn India Ventures

EntrackrEntrackr · 3m ago
StampMyVisa raises Rs 4 Cr in bridge round led by Unicorn India Ventures
Medial

Snippets StampMyVisa raises Rs 4 Cr in bridge round led by Unicorn India Ventures B2B visa processing platform StampMyVisa (SMV) has raised Rs 4 crore in a bridge round led by existing investor Unicorn India Ventures (UIV). The fresh capital will be used for growth, marketing and to support the company’s recent acquisition of Kunal Shah backed Teleport, which expands its operations in South India. Unicorn India Ventures had earlier invested Rs 6.6 crore in StampMyVisa during its seed round last year. The company aims to use this bridge round to achieve key milestones before raising a larger Series A round in the next financial year. StampMyVisa said it has achieved 4 times growth in revenue while maintaining a 99.5% visa success rate, processing more than 75,000 visas in the past six months. Its proprietary AI engine Nucleus automates and validates visa documentation for over 80 countries. The company recently introduced new products including SMV Insure, which refunds the booking value if a visa is rejected, and SMV Global, an eSIM service offering international connectivity at lower cost than regular roaming. It plans to expand into GCC markets and build fintech infrastructure with embedded credit and payment solutions for small and medium businesses. The platform targets to process 80% of visa applications within five minutes, compared to the current industry average of two days. In August 2025, StampMyVisa acquired travel tech startup Teleport, a consumer facing player backed by founders including Kunal Shah, Vidit Aatrey and Phanindra Sama. It competes with Atlys, Visa2Fly and StampThePassport.

Unicorn India Ventures closes Fund III at Rs 1,200 Cr

EntrackrEntrackr · 17d ago
Unicorn India Ventures closes Fund III at Rs 1,200 Cr
Medial

Unicorn India Ventures closes Fund III at Rs 1,200 Cr Deeptech-focused venture capital firm Unicorn India Ventures has closed its third fund at Rs 1,200 crore, surpassing its initial target of Rs 1,000 crore. LPs in Fund III include HNIs, UHNIs, family offices, and institutions. Backers include Sidbi, SBI, Nabard, and the state governments of Kerala, Madhya Pradesh, and Odisha. According to Unicorn India Ventures, the fund focuses on investments in semiconductors, spacetech, and AI infrastructure. The VC firm claims to have already seen strong early traction, with seven to eight portfolio companies witnessing substantial follow-on rounds. The fund will make 20 investments with an average ticket size of 10-15 crore. It plans to announce four investments in the coming months across quantum sensing, agritech, and spacetech. Across its three funds, the VC firm has built a portfolio of nearly 50 companies, with a total portfolio valuation of about $5 billion. The firm says that it is largely staying away from AI applications (SaaS) and focusing on AI infrastructure such as semiconductors, data centres, power, and enabling technologies. It is also actively exploring nuclear micro power generation as an enabler for AI. Another major trend playing out in the fund is the growing presence of academicians as startup founders. Four to five companies in Fund III are led by academicians, with one of them being a teaching academic. Unicorn India Ventures (UIV) is a Mumbai-based, SEBI-registered Alternative Investment Fund (AIF) launched in 2015 by Bhaskar Majumdar and Anil Joshi. It acts as an early-stage venture capital firm investing in technology-led startups, focusing on seed to pre-Series A rounds with investments ranging from Rs 1 to 10 crore. The firm supports B2B, SaaS, and DeepTech sectors, aiming to build, support, and scale companies, with over 60 investments to its credit.

ELIVAAS raises Rs 87 Cr in Series B round led by Vertex Ventures

EntrackrEntrackr · 6m ago
ELIVAAS raises Rs 87 Cr in Series B round led by Vertex Ventures
Medial

ELIVAAS raises Rs 87 Cr in Series B round led by Vertex Ventures Luxury vacation rental platform ELIVAAS has raised Rs 87 crore (approximately $10 million) in Series B funding led by Vertex Ventures Southeast Asia & India, with participation from existing investors Peak XV Partners’ Surge and 3one4 Capital. Entrackr had exclusively reported the development in April this year. In April 2024, the company raised $5 million in Series A funding led by 3one4 Capital, with participation from Peak XV Partners’ Surge and angel investors. The fresh proceeds will be used to expand its presence in India, prepare for entry into global markets, and invest in technology to scale operations. Sources indicate the company may have crossed Rs 500 crore in valuation. Founded in 2023 by Ritwik Khare and Karan Miglani, ELIVAAS manages luxury villas and apartments for short-term rentals. The platform serves both homeowners, by monetising and maintaining their properties, and travellers, by providing access to premium vacation accommodations. The company currently operates in 30 destinations across India and reported five-fold year-on-year revenue growth in FY25. While ELIVAAS has yet to disclose its FY25 numbers, the company recorded a revenue of Rs 7 crore and a loss of Rs 10.4 crore for the fiscal year ended March 2024, according to startup data intelligence platform TheKredible. Vertex Ventures Southeast Asia & India is an early-stage venture capital firm that partners with startups across Southeast Asia and India. It has invested in companies including Grab, FirstCry, Nium, Licious, Kuku FM, and PatSnap, supporting their growth across multiple sectors.

FutureCure Health raises Rs 104 Cr led by Carnelian Asset Management

EntrackrEntrackr · 1m ago
FutureCure Health raises Rs 104 Cr led by Carnelian Asset Management
Medial

FutureCure Health, a healthcare technology company focused on super-speciality care, has mopped up Rs 104 crore ($11.5 million) in a funding round led by Carnelian Asset Management LLP, with participation from other investors. The fundraising follows an earlier $4 million round in 2022 backed by Kotak Alternate Asset Management, RVCF Ventures, and Unicorn India Ventures. The fresh funds will be utilized to expand access to the diagnosis and treatment of vertigo, FutureCure Health said in a press release. Co-founded in 2015 by Rajneesh Bhandari and Anita Bhandari, FutureCure runs NeuroEquilibrium, its wholly owned subsidiary and a chain of vertigo and dizziness diagnostic and rehabilitation clinics. Unlike conventional approaches, NeuroEquilibrium focuses on identifying the root cause of vertigo, whether arising from the inner ear, the brain, or balance pathways, enabling targeted treatment rather than temporary relief. NeuroEquilibrium addresses a critical global gap in access to specialised neuro-otology care. By integrating advanced diagnostic systems, cloud-based remote platforms, and deep-tech innovation, it scales precision care beyond traditional urban centres, impacting patients worldwide while advancing cutting-edge medical technology. As NeuroEquilibrium scales across hospitals in India and globally and expands into chronic lifestyle diseases such as migraine and diabetes, it focuses on using technology to bridge the shortage of specialist doctors. Precise, scalable diagnostics can democratise super-speciality healthcare and act as a force multiplier for better outcomes. Working closely with hospitals, ENT clinics, and neurology centres, NeuroEquilibrium claims to operate over 300 clinics in India and 16 other countries and has enabled diagnosis and treatment for over 150,000 patients, significantly improving long-term outcomes.

Download the medial app to read full posts, comements and news.